{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.69 vs. cons $2.64",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core organic revenue growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~4.1% vs. cons 4.0%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Core adjusted EBITDA margin (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~15.2% vs. cons 15.0%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Core constant-currency revenue growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~4.0% vs. cons 4.0% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Cost-reduction synergies",
      "prediction": "UNCHANGED",
      "answer": "guide ~$900M vs. cons $900M (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$11.10 vs. cons $10.97 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.8,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Modest follow-through as an implied FY2026 adjusted-EPS outlook of ~$11.10 versus consensus of $10.97 supports upward revisions; approximately 4.0% core growth and unchanged $900M synergy guidance limit multiple expansion.",
  "day5_confidence": "MEDIUM"
}